ALK-Abello AS - Company Profile
Powered by
All the data and insights you need on ALK-Abello AS in one report.
- Save hours of research time and resources with
our up-to-date ALK-Abello AS Strategy Report
- Understand ALK-Abello AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on ALK-Abello AS’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into ALK-Abello AS's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Anders Hedegaard
Chairman Executive BoardMr. Anders Hedegaard has been the Chairman of the company since 2020. He also serves as the Chairman of the Remuneration & Nomination Committee and Member of the Scientific Committee. Mr. Hedegaard serves on the Board of Orphazyme AS.
Peter Halling
Chief Executive Officer; President Senior ManagementMr. Peter Halling has been the Chief Executive Officer and President of the company since January 2024. Prior to this, he served as the Chief Executive Officer of Fertin Pharma and Executive Vice President of Doehler Group. Previously, he served as the Vice President of Ingredion and Novozymes.
Claus Steensen Solje
Executive Vice President; Chief Financial Officer Senior ManagementMr. Claus Steensen Solje has been the Executive Vice President and Chief Financial Officer of the company since June 2023. Prior to this, he served as the Senior Vice President, International Operations and Chief Financial Officer for Novo Nordisk Emerging Markets. Mr. Solje also served as the Country Chief Financial Officer of Novo Nordisk France.
Per Plotnikof
Head - Investor Relations Senior ManagementSoren Niegel
Executive Vice President - Commercial Operations Senior ManagementHave you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer